SE522511C2 - System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase - Google Patents

System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase

Info

Publication number
SE522511C2
SE522511C2 SE0201920A SE0201920A SE522511C2 SE 522511 C2 SE522511 C2 SE 522511C2 SE 0201920 A SE0201920 A SE 0201920A SE 0201920 A SE0201920 A SE 0201920A SE 522511 C2 SE522511 C2 SE 522511C2
Authority
SE
Sweden
Prior art keywords
powder material
hydration
water
ability
phase
Prior art date
Application number
SE0201920A
Other languages
Swedish (sv)
Other versions
SE0201920L (en
SE0201920D0 (en
Inventor
Leif Hermansson
Haakan Engqvist
Lars Kraft
Nils-Otto Ahnfelt
Jesper Loeoef
Jan-Erik Schulz-Walz
Original Assignee
Doxa Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doxa Ab filed Critical Doxa Ab
Priority to SE0201920A priority Critical patent/SE522511C2/en
Publication of SE0201920D0 publication Critical patent/SE0201920D0/en
Priority to PCT/SE2003/000954 priority patent/WO2004000239A1/en
Priority to JP2004530933A priority patent/JP2005537832A/en
Priority to BR0311971-8A priority patent/BR0311971A/en
Priority to EP03733717A priority patent/EP1534212A1/en
Priority to CNB038144204A priority patent/CN1290483C/en
Priority to AU2003238999A priority patent/AU2003238999B2/en
Priority to RU2004138082/15A priority patent/RU2332201C2/en
Priority to CA002489823A priority patent/CA2489823A1/en
Priority to US10/518,084 priority patent/US7699925B2/en
Publication of SE0201920L publication Critical patent/SE0201920L/en
Publication of SE522511C2 publication Critical patent/SE522511C2/en
Priority to ZA200500277A priority patent/ZA200500277B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/70Preparations for dentistry comprising inorganic additives
    • A61K6/71Fillers
    • A61K6/77Glass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61K6/0205
    • A61K6/033
    • A61K6/06
    • A61K6/0643
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/802Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838Phosphorus compounds, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/853Silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/864Phosphate cements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/876Calcium oxide
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/34Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A system for dental filling material or implant (1) material, consists of water based hydration liquid and powdered material. The binder phase of powdered material consists of calcium-based cement system. The powdered material and/or hydration liquid comprises water-soluble phosphate or phase. The system forms apatite during hydration. A system for dental filling material or implant material and for bonding dental filling material or implant material between tooth and bone, respectively, consists of water-based hydration liquid and powdered material. The binder phase of powdered material consists of calcium based cement system. The powdered material is saturated with liquid, which is reacted with binder phase to hydrate chemically bonded ceramic material. The powdered material and/or hydration liquid comprises water-soluble phosphate or phase which forms water-soluble phosphate. The system forms apatite during hydration. Independent claims are also included for the following: (1) powdered material; (2) aqueous hydration liquid for powdered material; (3) implant material comprising substrate; and (4) method for achieving bonding dental filling material and implant material between tooth and bone, respectively.

Description

fula: 10 15 20 25 30 35 P1697 522 511 2 n - » c ø o o v ø u u c ø ø u u REDOGÖRELSE ÖVER UPPFINNINGEN Föreliggande uppfinning syfiar till att erbjuda ett system för framställning av ett kemiskt bundet keramiskt material av ett pulvermaterial vars bindefas huvudsakligen utgöres av ett kalciumbaserat cementsystem, vilket system uppvisar förmåga att bilda apatit in-situ. DESCRIPTION OF THE INVENTION The present invention aims to provide a system for producing a chemically bonded ceramic material from a powder material whose binder phase consists mainly of: -: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - a calcium-based cement system, which system exhibits the ability to form apatite in-situ.

Med förmåga att bilda apatit in-situ menas här att systemet innefattar nödvändiga be- ståndsdelar för bildning av apatit, t.ex. hydroxyapatit eller fluorapatit (Ca5(PO4)3OH respektive Ca5(PO4)3F) och eventuellt annan biologiskt gynnsam fas, och att systemet medger att dylika faser bildas under och/eller efier hydratiseringsreaktionen. Härigenom uppnås åtminstone den fördelen att apatit ej behöver tillsättas som ett separat tillsats- medel. Det bildade materialet kan sägas utgöra en kemiskt bunden keramisk komposit.By ability to form apatite in-situ is meant here that the system includes necessary constituents for the formation of apatite, e.g. hydroxyapatite or orurapatite (Ca5 (PO4) 3OH and Ca5 (PO4) 3F respectively) and any other biologically beneficial phase, and that the system allows such phases to be formed during and / or after the hydration reaction. This achieves at least the advantage that apatite does not need to be added as a separate additive. The formed material can be said to constitute a chemically bonded ceramic composite.

Att apatit bildas i materialet är ett tecken på att materialet är bioaktivt och samverkar med kroppen. Fördelningen av apatit blir vidare homogen i materialet, även i kontaktzoner mot biologiskt material, ben- och tandvävnad. Att apatit bildas i dylika kontaktzoner är speciellt gynnsamt för bindníngen. En arman fördel för apatitbildningen är att omgivningen är basisk. Eftersom apatit är ett kroppseget änme så kommer bind- ningssystemet att ge utomordentliga bindningsegenskaper med mycket tät anslutning mellan tandfyllnads/implantatrnaterialet och tanden/benet. Integreringen med omgivning med apatitinnehåll är mycket viktigt, speciellt för tandfyllnadsmaterial, orto- pediska massor och material som skikt på implantat. Det senare avser in-situ- preparerade ytskikt av kemiskt bunden keramkomposit baserad på apatit som har stor inverkan på benintegrering.The fact that apatite is formed in the material is a sign that the material is bioactive and interacts with the body. The distribution of apatite also becomes homogeneous in the material, even in contact zones with biological material, bone and tooth tissue. The fact that apatite is formed in such contact zones is particularly favorable for binding. Another advantage of apatite formation is that the environment is alkaline. Since apatite is a body-specific substance, the bonding system will provide excellent bonding properties with a very close connection between the dental filling / implant material and the tooth / bone. The integration with environments with apatite content is very important, especially for dental filling materials, orthopedic masses and materials such as layers on implants. The latter refers to in-situ prepared surface layers of chemically bonded ceramic composite based on apatite which have a great effect on bone integration.

Enligt uppfinningen presenteras således ett system för tandfyllnadsmaterial eller implantatmaterial, ett pulvermaterial samt en hydratiseringsvätska, enligt de efter- följande patentkraven.According to the invention, a system for dental filling material or implant material, a powder material and a hydrating fluid are thus presented, according to the following patent claims.

Pulvermaterialet Pulvermaterialet utgöres av ett kalciuminnehållande basiskt kerampulver av aluminater, silikater, fosfater, sulfater och kombinationer därav, företrädesvis aluminater, Enligt uppfinningen innefattar pulvermaterialet vattenlöslíg fosfat, varigenom cementsystemet uppvisar förmåga att under hydratiseringen bilda apatit.The powder material The powder material consists of a calcium-containing basic ceramic powder of aluminates, silicates, phosphates, sulphates and combinations thereof, preferably aluminates. According to the invention, the powder material comprises water-soluble phosphate, whereby the cement system has the ability to form apatite during hydration.

Vidare gäller att: a. Sagda vattenlösli ga fosfat kan utgöras av vattenlöslíg fosfatinnehållande fas, t ex alkalifosfater.Furthermore, it applies that: a. Said water-soluble phosphate may consist of a water-soluble phosphate-containing phase, eg alkali phosphates.

Effekt: höjning av fosfatandelen i materialet, ger högre halt av apatit (ej endast begränsat till fosfatinnehållet i lösningen), nous» 10 15 20 25 30 35 Pl697 522 511 3 n :nu u Materialet kan innefatta groddar av fosfatinnehållande fas, företrädesvis hydroxy- och fluorapatit, Effekt: styming av utfallning av apatit, Materialet kan innefatta tillsats av kollagen, elastin eller andra högmolekylära protein som in-situ-beläggs eller förbeläggs med apatit ur mättad lösning.Effect: increase of the phosphate content of the material, gives a higher content of apatite (not only limited to the phosphate content of the solution), nous »10 15 20 25 30 35 Pl697 522 511 3 n: nu u The material may comprise sprouts of phosphate-containing phase, preferably hydroxy. and fl uorapatite, Effect: control of apatite precipitation, The material may comprise the addition of collagen, elastin or other high molecular weight proteins which are in-situ coated or pre-coated with apatite from saturated solution.

Effekt: för att styra utfallningen av apatit, Materialet kan innefatta tillsats av fluorinnehållande fas av icke svårlöslig karaktär, t.ex. fluorid-innehållande glas (glasjonomerglas) av icke svårlöslig karaktär, i halter understigande 10 %. Andra exempel på fluorinnehållande fas är kalciumfluorid (CaFz) eller natriumfluorid (NaF), d.v.s. fluoridföreningar som är lösliga i vatten.Effect: to control the precipitation of apatite, The material may include the addition of fluorine-containing phase of non-soluble nature, e.g. fl uoride-containing glass (glass ionomer glass) of a non-soluble nature, in contents of less than 10%. Other examples of or-fluorine-containing phase are calcium fluoride (CaF2) or sodium fluoride (NaF), i.e. fl uoride compounds that are soluble in water.

Effekt: ett sätt att få in fluor i materialet varvid det kan bildas fluorapatit.Effect: a way to get fl uor into the material whereby or uorapatite can form.

Materialet kan innefatta karbonat eller biologiskt förekommande joner som kan bilda: oxalater, laktater, kalcit, aragonit. Till exempel kan karbonatjoner bilda kalcit och kalcium kan bilda svårlösliga biologiska salter med mjölksyrans anjon, laktat etc.The material may include carbonate or biologically present ions which may form: oxalates, lactates, calcite, aragonite. For example, carbonate ions can form calcite and calcium can form insoluble biological salts with lactic anion, lactate, etc.

Effekt: genom att styra koncentrationen och sammansättningen av jonema kan olika biologiska faser som innehåller Ca utfallas. Gäller även vattenlösliga tillsatser i pulverråvaran.Effect: by controlling the concentration and composition of the ions, different biological phases containing Ca can be precipitated. Also applies to water-soluble additives in the powder raw material.

Pulvermaterialet kan föreligga som en råpresskropp som företrädesvis uppvisar en kompaktgrad av åtminstone 55 volym-% fast fas, än mer föredraget åtmin- stone 60 volym-% fast fas, mest föredraget åtminstone 65 volym-% fast fas och allra mest föredraget åtminstone 70 volym-% fast fas, Alternativt kan pulvermaterialet föreligga i lös pulverforrn, varvid det blandas med hydratiseringsvätskan till en slamma som sedan dräneras och kompakteras.The powder material may be in the form of a crude body which preferably has a compact of at least 55% by volume of solid phase, more preferably at least 60% by volume of solid phase, most preferably at least 65% by volume of solid phase and most preferably at least 70% by volume. Alternatively, the powder material may be in the loose powder form, whereby it is mixed with the hydration liquid to a sludge which is then drained and compacted.

Det är speciellt föredraget att cementsystemets huvudbindefas utgörs av kalcium- aluminat (Ca-aluminat), eftersom: l. 2.It is especially preferred that the main binder phase of the cement system consists of calcium aluminate (Ca-aluminate), since: 1. 2.

Ca-aluminater ger basisk närmiljö till apatit, vilket gör denna fas stabil (ej upplösning, hinder för plaque-bildning och mjölksyrabildning) Ca-aluminat finns i överskott och utbildas i alla porer i materialet - bidrager till utfyllnad av materialet- om enbart apatit skulle utnyttjas så omsätts för lite vatten för att vattenfylld porositet ska kunna fyllas med hydrat.Ca-aluminates provide an alkaline environment for apatite, which makes this phase stable (not dissolution, obstacles to plaque formation and lactic acid formation) Ca-aluminate is present in excess and is formed in all pores in the material - contributes to filling in the material - if only apatite should is used, too little water is converted so that water-filled porosity can be filled with hydrate.

Ca-aluminat utfälls genom syra-bas reaktion, där vatten reagerar med pulver- materialet, som börjar upplösas. I lösningen finns alla byggstenar som behövs för att bilda både kalciumaluminathydrat, gibbsit samt apatit (om fosfor tillförs i någon form) och eventuellt annan biologiskt gynnsam fas (kalcit, aragonit, laktat rføso 10 15 20 25 30 35 P1697 522 511 4 etc). När löslighetsprodukten för vart ämne nås börjar en utfallning. Utfallningen sker överallt, inkluderat i mikroutrymmen mellan fyllningsmaterialet och tandvägg. Småkristaller fälls ut i yt-topografin i tandväggen eller annan bio- logisk kontaktyta och bidrager till att kontaktzonen fyllningsmaterial-tand/ben helt försvinner innebärande mikrostrukturell integrering. I förstomingar upp till 20000 gånger kan ej någon spalt upptäckas.Ca-aluminate precipitates by acid-base reaction, where water reacts with the powder material, which begins to dissolve. The solution contains all the building blocks needed to form both calcium aluminate hydrate, gibbsite and apatite (if phosphorus is added in some form) and any other biologically favorable phase (calcite, aragonite, lactate rføso 10 15 20 25 30 35 P1697 522 511 4 etc). When the solubility product for each substance is reached, precipitation begins. The precipitation takes place everywhere, including in the micro-spaces between the filling material and the tooth wall. Small crystals precipitate in the surface topography of the tooth wall or other biological contact surface and contribute to the contact zone filling material-tooth / bone disappearing completely, meaning microstructural integration. In constellations up to 20,000 times, no gap can be detected.

Sammanfattningsvis: Ca-aluminat är fördelaktigt vid apatitnärvaro för att a. b.In summary: Ca-aluminate is beneficial in the presence of apatite to a. B.

Skydda apatiten för kemisk upplösning vid lågt pH, Tillse att en tät produkt föreligger/utbildas. (Pumpen i systemet är Ca-, aluminat- och OH- joner). Övriga tillsatta joner som fosfater, fluorider, karbonater etc. ger sekundär kompletterande rent biologisk fas, Medverka till att helt tät kontaktzon utbildas (mikrostrukturell integrering) Hydratiseringsvätskan Hydratiseringsvätskan utgöres av en vattenbaserad vätska som enligt uppfinningen innefattar vattenlöslig fosfat, varigenom cementsystemet uppvisar förmåga att under hydratiseringen bilda apatit.Protect the appetite from chemical dissolution at low pH, Ensure that a dense product is present / formed. (The pump in the system is Ca, aluminate and OH ions). Other added ions such as phosphates, fluorides, carbonates, etc. provide a secondary complementary purely biological phase. Contribute to the formation of a completely dense contact zone (microstructural integration) The hydration fluid form apatite.

Vidare gäller att: a) b) d) Sagda vattenlösliga fosfat bildar fosfatjoner i vätskan, företrädesvis PO43' , HPOf, H2PO4' eller annan fosforinnehållande jon.Furthermore, a) b) d) said water-soluble phosphate forms phosphate ions in the liquid, preferably PO43 ', HPOf, H2PO4' or other phosphorus-containing ion.

Vätskan kan innefatta karbonatjoner eller biologiskt förekommande joner som kan bilda: oxalater, laktater, kalcit, aragonit. Till exempel kan karbonatjoner bilda kalcit och kalcium kan bilda svårlösliga biologiska salter med mjölksyrans anjon, laktat etc.The liquid may comprise carbonate ions or biologically present ions which may form: oxalates, lactates, calcite, aragonite. For example, carbonate ions can form calcite and calcium can form insoluble biological salts with lactic anion, lactate, etc.

Effekt: genom att styra koncentrationen och sammansättningen av jonema kan olika biologiska faser som innehåller Ca utfállas, Koncentration av fosfatjoner bör vara 0.01- 5 M, företrädesvis 0.1-2 M, mest föredraget 0.5- 1.5M.Effect: by controlling the concentration and composition of the ions, various biological phases containing Ca can be precipitated. Concentration of phosphate ions should be 0.01- 5 M, preferably 0.1-2 M, most preferably 0.5- 1.5 M.

Effekt: Hög koncentration ger mer apatitfas, pH bör justeras till åtminstone 7, företrädesvis 7-12,5 och än mer föredraget 7-11, Effekt: pH styr jämvikt för utfällning av apatit och katoit (huvudfas i Ca- aluminat-hydratsystemet vid kroppstemperatur), Isaac 10 15 P1697 522 511 5 a <øøo u e) Vätskan kan innefatta tillsats av fluoridjoner till en koncentration fluoridjoner i intervallet 0.01-5 M, företrädesvis O. 1-2 M, mest föredraget 0.5-1 M, Effekt: ger utbildning av fluorapatit jämte katoit. (F luorapatit är ännu stabilare än hydroxyapatit), f) Vätskan kan innefatta accelerator och/eller vätskereducerande medel.Effect: High concentration gives more apatite phase, pH should be adjusted to at least 7, preferably 7-12.5 and even more preferably 7-11, Effect: pH controls equilibrium for precipitation of apatite and katoite (main phase in the Ca-aluminate hydrate system at body temperature ), Isaac 10 15 P1697 522 511 5 a <øøo ue) The liquid may comprise addition of fl uoride ions to a concentration fl uoride ions in the range 0.01-5 M, preferably O. 1-2 M, most preferably 0.5-1 M, Effect: provides training of fl uorapatite along with katoit. (Fluoroapatite is even more stable than hydroxyapatite), f) The liquid may include accelerator and / or liquid reducing agent.

Uppfinningen är ej begränsad av till de föredragna utföringsformema utan kan varieras inom patentkraven. Det skall speciellt inses att andra aspekter för systemet/pulver- materialet/hydratiseringsvätskan följa det som beskrivs i SE 463 493, SE 502 987, WO 00/21489, WO 01/76534, WO 01/76535, SE-AO- 0103189-7 eller SE-A0-0103190-5, vilka aspekter härmed inkorporeras genom referens. Det skall vidare förstås att pul- vermaterialet respektive hydratiseringsvätskan kan användas i kombination men också var för sig och då tillsammans med konventionella hydratiseringsvätskor respektive pulvermaterial, t.ex. de som beskrivs i nyss nämnda äldre patentansökningar.The invention is not limited to the preferred embodiments but can be varied within the claims. In particular, it should be understood that other aspects of the system / powder material / hydration fluid follow that described in SE 463 493, SE 502 987, WO 00/21489, WO 01/76534, WO 01/76535, SE-AO-0103189-7 or SE-A0-0103190-5, which aspects are hereby incorporated by reference. It is further to be understood that the powder material or the hydrating liquid can be used in combination but also separately and then together with conventional hydrating liquids and powder material, e.g. those described in the just mentioned older patent applications.

Claims (1)

1. 0 15 20 25 30 35 Pl697 522 511 6 PATENTKRAV 1. System för tandfyllnadsmaterial eller implantatmaterial, innefattande en vatten- baserad hydratiseringsvätska samt ett pulvermaterial vars bindefas huvudsak- ligen utgöres av ett kalciumbaserat cementsystem, vilket pulvermaterial uppvisar förmågan att efter genomdränkning med den med bindefasen reagerande hydra- tiseringsvätskan hydratisera till ett kemiskt bundet keramiskt material, k ä n n e t e c k n at a v att sagda pulvermaterial och/eller sagda hydratiserings- vätska innefattar vattenlöslig fosfat, varigenom systemet uppvisar förmåga att under hydratiseringen bilda apatit. System enligt krav 1, k ä n n e t e c k n at a v att systemet uppvisar förmåga att under hydratiseringen bilda 0,01-30 volym-% apatit i systemet. System enligt krav 1 eller 2, kän n et e c k n at av att systemet uppvisar ett pH av åtminstone 7, företrädesvis 7-12,5 och än mer föredraget 7-1 1, företrädesvis genom utnyttjande av buffertsystem av t.ex. fosfater eller karbonater. Pulvermaterial vars bindefas huvudsakligen utgöres av ett kalciumbaserat cementsystem, vilket pulvermaterial uppvisar förmågan att efier genom- dränkning med en med bindefasen reagerande hydratiseringsvätska hydratisera till ett kemiskt bundet keramiskt material, k ä n n et e c k n at a v att pulver- materialet innefattar vattenlöslig fosfat, varigenom cementsystemet uppvisar förmåga att under hydratiseringen bilda apatit. Pulvermaterial enligt krav 4, k ä n n e t e c k n at a v att cementsystemet uppvisar förmåga att under hydratiseringen bilda 0,01-30 volym-% apatit i cement- systemet. Pulvermaterial enligt något av kraven 4-5, k ä n n e t e c k n at a v att sagda kalciumbaserade cementsystem utgöres av ett cementsystem i gruppen som består av aluminater, silikater, fosfater, sulfater och kombinationer därav, företrädesvis aluminater. Pulvermaterial enligt något av kraven 4-6, k ä n n e t e c k n at a v att sagda vattenlösli ga fosfat utgöres av ett alkalifosfat. -v- u. .- 10 15 20 25 30 35 PI697 8. 10. 11. 12. 13. 14 15. 522 511 v Pulvermaterial enligt något av kraven 4-7, k ä n n e t e c k n at a v att det även innefattar groddar av fosfatinnehållande fas, företrädesvis hydroxy- eller fluorapatit. Pulvermaterial enligt något av kraven 4-8, k ä n n e t e c k n at a v att det även innefattar högmolekylära protein, företrädesvis kollagen eller elastin. Pulvermaterial enligt något av kraven 4-9, k ä n n e t e c k n at a v att det även innefattar fluorinnehållande fas av icke svårlöslig karaktär, företrädesvis i halter av från 0,5 % och upp till 10 %. Pulvermaterial enligt något av kraven 4-10, k ä n n et e c k n a t a v att det innefattar karbonat eller biologiskt förekommande joner som uppvisar förmåga att bilda kalcit och/eller aragonit, oxalater, laktater, citrater. Pulvermaterial enligt något av kraven 4-11, k ä n n et e c k n at a v att det föreligger i form av en råpresskropp som företrädesvis uppvisar en kompaktgrad av åtminstone 55 volym-% fast fas, än mer föredraget åtminstone 60 volym-% fast fas, mest föredraget åtminstone 65 volym-% fast fas och allra mest före- draget åtminstone 70 volym-% fast fas. Vattenbaserad hydratiseringsvâtska för ett pulvermaterial vars bindefas huvud- sakligen utgöres av ett kalciumbaserat cementsystem, vilket pulvermaterial upp- visar förmågan att efter genomdränkning med den med bindefasen reagerande hydratiseringsvätskan hydratisera till ett kemiskt bundet keramiskt material, k ä n n e t e c k n a d a v att hydratiseringsvätskan innefattar vattenlöslig fosfat, varigenom cementsystemet uppvisar förmåga att under hydratiseringen bilda apatit. _ Hydratiseringsvätska enligt krav 13, k ä n n et e c k n a d a v att sagda vattenlösliga fosfat föreligger i en mängd av åtminstone 0,01-5 M, företrädesvis 0.1-2 M och än mer föredraget 0,5-1,5 M. Hydratiseringsvätska enligt något av kraven 13- 14, k ä n n et e c k n a d a v att sagda vattenlösliga fosfat innefattar fosfatjoner i gruppen som består av PO43', HPOÛ, H2POJ, ammoniumvätefosfat och andra fosforinnehållande joner. 1:11» 10 15 v | | u u 16. Hydratiseringsvätska enligt något av kraven 13-15, k ä n n e t e c k n a d a v att den uppvisar ett pH av åtminstone 7, företrädesvis 7-12,5 och än mer föredraget 7-11, företrädesvis genom utnyttjande av buffertsystem av tex. fosfater eller karbonater. 17. Hydratiseringsvätska enligt något av kraven 13-16, k ä n n e t e c k n a d a v att den innefattar karbonatjoner eller biologiskt förekommande joner som uppvisar förmåga att bilda kalcit och/eller aragonit, oxalater, laktater, citrater. 18. Hydratiseringsvätska enligt något av kraven 13-17, k ä n n e t e c k n a d a v att den innefattar fluoridjoner, företrädesvis i en halt av 0.01-5 M, än mer föredraget O. 1-2 M och mest föredraget O.5-1 M. 19. Hydratiseringsvätska enligt något av kraven 13-18 k ä n n e t e c k n a d a v att den innefattar en accelerator och/eller ett vätskereducerande medel.A system for dental filling material or implant material, comprising an aqueous hydration fluid and a powder material whose binder phase consists mainly of a calcium-based cement system, which powder material has the ability to, after soaking with the hydrate the hydrating liquid reacting with the binder phase to a chemically bonded ceramic material, characterized in that said powder material and / or said hydrating liquid comprise water-soluble phosphate, whereby the system exhibits the ability to form apatite during the hydration. System according to claim 1, characterized in that the system exhibits the ability to form 0.01-30% by volume of apatite in the system during hydration. System according to claim 1 or 2, characterized in that the system has a pH of at least 7, preferably 7-12.5 and even more preferably 7-1 1, preferably by using buffer systems of e.g. phosphates or carbonates. Powder material whose binder phase consists mainly of a calcium-based cement system, which powder material has the ability to hydrate a soak with a binder phase-reactive hydration liquid to a chemically bonded ceramic material, characterized in that the powder material comprises a water-soluble system. exhibits the ability to form apatite during hydration. Powder material according to Claim 4, characterized in that the cement system has the ability to form 0.01-30% by volume of apatite in the cement system during hydration. Powder material according to any one of claims 4-5, characterized in that said calcium-based cement system consists of a cement system in the group consisting of aluminates, silicates, phosphates, sulphates and combinations thereof, preferably aluminates. Powder material according to any one of claims 4-6, characterized in that said water-soluble phosphate consists of an alkali phosphate. -v- u. .- 10 15 20 25 30 35 PI697 8. 10. 11. 12. 13. 14 15. 522 511 v Powder material according to any one of claims 4-7, characterized in that it also comprises sprouts of phosphate-containing phase, preferably hydroxy- or orurapatite. Powder material according to any one of claims 4-8, characterized in that it also comprises high molecular weight proteins, preferably collagen or elastin. Powder material according to any one of claims 4-9, characterized in that it also comprises a non-soluble phase of a non-soluble nature, preferably in contents of from 0.5% and up to 10%. Powder material according to any one of claims 4-10, characterized in that it comprises carbonate or biologically present ions which have the ability to form calcite and / or aragonite, oxalates, lactates, citrates. Powder material according to any one of claims 4-11, characterized in that it is in the form of a crude body which preferably has a compact degree of at least 55% by volume of solid phase, even more preferably at least 60% by volume of solid phase, most preferably at least 65% by volume solid phase and most preferably at least 70% by volume solid phase. Aqueous hydrating liquid for a powder material whose binder phase consists mainly of a calcium-based cement system, which powder material exhibits the ability to hydrate after soaking with the binder phase-reactive hydration liquid to a chemically bonded ceramic material, characterized in that the hydrating liquid exhibits the ability to form apatite during hydration. Hydration fluid according to claim 13, characterized in that said water-soluble phosphate is present in an amount of at least 0.01-5 M, preferably 0.1-2 M and even more preferably 0.5-1.5 M. Hydration fluid according to any one of Claims 13-14, characterized in that said water-soluble phosphate comprises phosphate ions in the group consisting of PO43 ', HPOÛ, H2POJ, ammonium hydrogen phosphate and other phosphorus-containing ions. 1:11 »10 15 v | | Hydration fluid according to any one of claims 13-15, characterized in that it has a pH of at least 7, preferably 7-12.5 and even more preferably 7-11, preferably by using buffer systems of e.g. phosphates or carbonates. Hydrating fluid according to any one of claims 13-16, characterized in that it comprises carbonate ions or biologically present ions which have the ability to form calcite and / or aragonite, oxalates, lactates, citrates. Hydration fluid according to any one of claims 13-17, characterized in that it comprises fluride ions, preferably at a level of 0.01-5 M, even more preferably O. 1-2 M and most preferably O.5-1 M. 19. Hydration fluid according to any one of claims 13-18, characterized in that it comprises an accelerator and / or a fluid reducing agent.
SE0201920A 2002-06-20 2002-06-20 System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase SE522511C2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0201920A SE522511C2 (en) 2002-06-20 2002-06-20 System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase
US10/518,084 US7699925B2 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
EP03733717A EP1534212A1 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
JP2004530933A JP2005537832A (en) 2002-06-20 2003-06-11 Teeth filling material or implant material system and method for achieving powder material, hydration water, implant material and bonding
BR0311971-8A BR0311971A (en) 2002-06-20 2003-06-11 System for the production of a dental filler or implant material, and powder material, hydration liquid, implant material and method of obtaining a bond
PCT/SE2003/000954 WO2004000239A1 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
CNB038144204A CN1290483C (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
AU2003238999A AU2003238999B2 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
RU2004138082/15A RU2332201C2 (en) 2002-06-20 2003-06-11 Composition of dental filling material or implant material, powder material, hydration fluid, implant material and method of cohesion
CA002489823A CA2489823A1 (en) 2002-06-20 2003-06-11 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
ZA200500277A ZA200500277B (en) 2002-06-20 2005-01-12 System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201920A SE522511C2 (en) 2002-06-20 2002-06-20 System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase

Publications (3)

Publication Number Publication Date
SE0201920D0 SE0201920D0 (en) 2002-06-20
SE0201920L SE0201920L (en) 2003-12-21
SE522511C2 true SE522511C2 (en) 2004-02-10

Family

ID=20288278

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201920A SE522511C2 (en) 2002-06-20 2002-06-20 System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase

Country Status (2)

Country Link
SE (1) SE522511C2 (en)
ZA (1) ZA200500277B (en)

Also Published As

Publication number Publication date
SE0201920L (en) 2003-12-21
ZA200500277B (en) 2006-07-26
SE0201920D0 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
Shah Fluoride-containing bioactive glasses: Glass design, structure, bioactivity, cellular interactions, and recent developments
JP2773752B2 (en) Storage stable formulations for calcium phosphate minerals prepared in situ
US5320844A (en) Composite materials for hard tissue replacement
Osorio et al. Zinc induces apatite and scholzite formation during dentin remineralization
JP2863544B2 (en) Method for producing calcium phosphate mineral
LeGeros Formation and transformation of calcium phosphates: relevance to vascular calcification
US6461632B1 (en) Hardenable ceramic hydraulic cement
CN102631702B (en) The complex of mineralized collagen and bioceramic and manufacture method thereof
US7083672B2 (en) Method and product for phosphosilicate slurry for use in dentistry and related bone cements
CN1658913A (en) Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
JP2008539916A (en) Bioactive bone cement and method for producing the same
Ślósarczyk et al. The effect of phosphate source on the sintering of carbonate substituted hydroxyapatite
Pina et al. Injectability of brushite-forming Mg-substituted and Sr-substituted α-TCP bone cements
US7699925B2 (en) System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
SE522511C2 (en) System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase
SE522510C2 (en) System for dental filling material or implant material consists of water-based hydration liquid and powdered material comprising water-soluble phosphate or phase
US9056097B2 (en) Composite of amorphous calcium phosphate/calcium sulfate hemihydrate (CSH/ACP) for bone implantation and process for producing the same
Dorozhkin Calcium phosphates and human beings
EP3325030B1 (en) Bone graft system
EP1189851B1 (en) Sintered hydroxyapatite compositions and method for the preparation thereof
JP2742814B2 (en) Root canal filling material
Tay Bioactivity of mineral trioxide aggregate and mechanism of action
Şahin Synthesis and characterization of calcium phosphate cement based macroporous scaffolds
Djustiana et al. Hardness evaluation of carbonate apatite cement based on various ratio of precursor
JPH06100410A (en) Calcium phosphate-based filler

Legal Events

Date Code Title Description
NUG Patent has lapsed